A meta-analysis found that oral magnesium supplementation alone in hemodialysis (HD) patients improved chronic kidney disease-mineral-bone disease (CKD-MBD) by modulating serum Ca and parathyroid hormone (PTH) metabolism and improving carotid intima-media thickness reduction [53]. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.